Riik: Austraalia
keel: inglise
Allikas: Department of Health (Therapeutic Goods Administration)
Sysmex Australia Pty Ltd
Class 3
Cytocell Ltd 418 Cambridge Science Park Milton Road, Oxford Gene Technology, Cambridge, CB4 0PZ United Kingdom
CT929 - Acquired genetic alteration IVDs
IVDs that are intended to be used in genetic testing to provide information about acquired genetic alterations, which may include chromosomal alterations, mutations and/or alterations in gene expression, and which may be used to characterise haematological or solid tumour malignancies and/or provide prognostic information. These products are intended for use as an adjunct to classic cytogenetics and not as independent tests or assays.
A
2014-07-21